212 related articles for article (PubMed ID: 27769766)
21. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
22. [Hormonal treatment effectivity in hyperandrogenic syndrome].
Visnovský J; Biringer K; Svecová I; Biringerová Z
Ceska Gynekol; 2010 Oct; 75(5):481-5. PubMed ID: 21374929
[TBL] [Abstract][Full Text] [Related]
23. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Chung JP; Yiu AK; Chung TK; Chan SS
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
25. Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms.
Erkkola R; Hirvonen E; Luikku J; Lumme R; Männikkö H; Aydinlik S
Acta Obstet Gynecol Scand; 1990; 69(1):61-5. PubMed ID: 2140663
[TBL] [Abstract][Full Text] [Related]
26. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
[TBL] [Abstract][Full Text] [Related]
27. Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
Naka KK; Kalantaridou SN; Bechlioulis A; Kravariti M; Kazakos N; Katsouras CS; Tsatsoulis A; Michalis LK
Gynecol Endocrinol; 2011 Sep; 27(9):615-21. PubMed ID: 21329419
[TBL] [Abstract][Full Text] [Related]
28. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.
Seaman HE; de Vries CS; Farmer RD
Pharmacoepidemiol Drug Saf; 2003; 12(7):541-50. PubMed ID: 14558177
[TBL] [Abstract][Full Text] [Related]
29. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
Acién P; Mauri M; Gutierrez M
Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
[TBL] [Abstract][Full Text] [Related]
30. The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate.
Eden JA
Med J Aust; 1991 Nov; 155(10):677-80. PubMed ID: 1834923
[TBL] [Abstract][Full Text] [Related]
31. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
32. Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Ibáñez L; Díaz M; Sebastiani G; Marcos MV; López-Bermejo A; de Zegher F
J Clin Endocrinol Metab; 2013 May; 98(5):E902-7. PubMed ID: 23547047
[TBL] [Abstract][Full Text] [Related]
33. Antiandrogens in the treatment of acne and hirsutism.
Hammerstein J; Moltz L; Schwartz U
J Steroid Biochem; 1983 Jul; 19(1B):591-7. PubMed ID: 6224974
[TBL] [Abstract][Full Text] [Related]
34. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
Carmina E; Lobo RA
Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
[TBL] [Abstract][Full Text] [Related]
35. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
36. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Prelević GM; Puzigaća Z; Balint-Perić LA
Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
[No Abstract] [Full Text] [Related]
37. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702
[TBL] [Abstract][Full Text] [Related]
38. [Management of virilization with an antiandrogen-containing contraceptive].
Apró G; Sas M
Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
[TBL] [Abstract][Full Text] [Related]
39. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Beigi A; Sobhi A; Zarrinkoub F
Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
